X

Trial Profile

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR): A Randomized, Double-Blind, Placebo-Controlled Trial With Incomplete Crossover

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ECCS 50 (Primary)
Indications Raynaud's disease; Scleroderma; Systemic scleroderma
Focus Registrational; Therapeutic Use
Acronyms STAR
Sponsors Cytori Therapeutics; Plus Therapeutics

Most Recent Events

01 Jun 2018 Status changed from active, no longer recruiting to completed.
15 Feb 2018 According to a Cytori Therapeutics media release, the company is currently working with statisticians and study investigators in preparation for publication of these results in a peer-reviewed journal.
15 Feb 2018 Results presented in a Cytori Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com